Tags: Drug.

Pimavanserin (ACP-103) is a drug developed by Acadia Pharmaceuticals which acts as an inverse agonist on the serotonin receptor subtype 5-HT2A with 40x selectivity over 5-HT2C and no significant affinity or activity at 5-HT2B or dopamine receptors.

Pimavanserin2DACS2.svg
ATC prefix
none
CAS number
706779-91-1
CAS supplemental
706782-28-7 (tartrate)
FDA UNII code
JZ963P0DIK
IUPAC name
N-(4-fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl)carbamide
PubChem
10071196

Loading...

This page contains content from the copyrighted Wikipedia article "Pimavanserin"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.